Dr. Laura Finn brings new treatment options to Louisiana using genetically altered cells to treat blood cancer patients. Here ...

A growing number of physicians are starting to shift their thinking about multiple myeloma’s prognosis. For years, patients ...

A New York City federal court has dismissed a proposed class action lawsuit against Bristol Myers Squibb that accused the ...

Early infection incidence in patients with multiple myeloma following treatment with cilta-cel infusion highlights the ...

Dr. Surbhi Sidana discussed the topic of minimal residual disease during the CURE Educated Patient® Multiple Myeloma Summit.

Hematologist-oncologist Mateo Mejia Saldarriaga, MD, combines clinical care with research aimed at helping patients with ...

Therapy-related B-lymphoblastic leukemia (B-ALL) following treatment for multiple myeloma is a rare occurrence.

In a live virtual event, Attaya Suvannasankha, MD, discussed the MajesTEC-1 trial of teclistamab and approaches to mitigation ...

Marc Raab, MD, PhD, discussed the MajesTEC-5 trial of teclistamab plus standard myeloma therapies in transplant-eligible ...

The main character 'Gwansik' in the recently popular Netflix drama 'I've been tricked' has died of multiple myeloma, making ...

The study highlights the importance of including patient self-assessment—and not just clinician assessment—when planning ...

Several studies have been conducted, but questions remain about where such therapies will fit into multiple myeloma treatment ...